Combined with results from the first prospective study (Fig. 2C), these real-world clinical studies reveal a striking performance of negative LIMA1 IHC staining in recognizing patients that will not die of HNSCC during a clinically relevant follow-up period. Here, LIMA1 is linked to head and neck squamous cell carcinoma.